Rare diseases
Investigational molecules
Locations
Back to Italy39 clinical trials in Leghorn, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive investigations into HER2-positive and hormone receptor-positive breast cancer treatments. Studies focus on novel therapeutic combinations and targeted approaches for different stages of breast cancer.
Multiple trials evaluating innovative drug combinations and immunotherapy approaches for better patient outcomes.
Research centered on non-small cell lung cancer (NSCLC) treatments, investigating immunotherapy combinations and targeted therapies for various stages of the disease.
Focus on improving survival rates through innovative treatment approaches and combinations.
Investigations into advanced colorectal cancer treatments, including studies on specific mutations and combination therapies for metastatic disease.
Emphasis on personalized treatment strategies based on specific genetic markers and disease characteristics.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
